Published in Women's Health Weekly, January 27th, 1997
The synthetic version of DHEA is believed to be more effective and without the side effects of the natural steroid. Aeson Therapeutics Inc. (ATI), Tucson, Arizona, has supported the initial clinical development of fluasterone, a synthetic version of DHEA (dehydroepiandrosterone).
ATI designed its plan to show fluasterone's nonandrogenicity in humans and to establish its effectiveness in preventing breast cancer and treating other diseases such as lupus erythematosus and Type II diabetes.
Laboratory experiments suggest DHEA could...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.